Evid Invest
Holders — by stockHoldings — by fund

Privium Fund Management B.V.

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-09-30 · filed with the SEC up to 45 days after quarter end · CIK 0001795097

$515.5M

disclosed book value

58

positions

15.5%

largest position share

Positions, as of 2026-09-30

top 58 of 58 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1TSLATESLA INC225,000$79.8M15.5%
2SHOPSHOPIFY INC305,000$45.2M8.8%
3AMDADVANCED MICRO DEVICES INC62,000$37.9M7.4%
4SPCXSPACE EXPLORATION TECHN CORP250,000$37.7M7.3%
5PLTRPALANTIR TECHNOLOGIES INC200,000$37.4M7.3%
6AMZNAMAZON COM INC140,000$34.9M6.8%
7CBRSCEREBRAS SYSTEMS INC111,000$19.7M3.8%
8NVDANVIDIA CORPORATION81,000$18.5M3.6%
9SPOTSPOTIFY TECHNOLOGY S A33,000$16.1M3.1%
10IONSIONIS PHARMACEUTICALS INC349,003$15.6M3%
11IRENIREN LIMITED370,150$15.1M2.9%
12ARWRARROWHEAD PHARMACEUTICALS IN215,818$14.1M2.7%
13LMNDLEMONADE INC270,259$12.2M2.4%
14OPENOPENDOOR TECHNOLOGIES INC5.1M$12.2M2.4%
15BIIBBIOGEN INC48,400$10.9M2.1%
16NBISNEBIUS GROUP N.V.40,000$9.4M1.8%
17PRQRPROQR THRAPEUTICS N V5.5M$9.1M1.8%
18ARQTARCUTIS BIOTHERAPEUTICS INC333,193$8.8M1.7%
19AXSMAXSOME THERAPEUTICS INC.42,944$7.9M1.5%
20BBIOBRIDGEBIO PHARMA INC89,151$5.9M1.1%
21QUREUNIQURE NV216,197$5.2M1%
22ALNYALNYLAM PHARMACEUTICALS INC20,607$5.1M1%
23DNLIDENALI THERAPEUTICS INC229,857$4.8M0.9%
24BMRNBIOMARIN PHARMACEUTICAL INC75,000$4.5M0.9%
25URGNUROGEN PHARMA LTD107,915$4.4M0.9%
26NBIXNEUROCRINE BIOSCIENCES INC26,200$3.7M0.7%
27RAREULTRAGENYX PHARMACEUTICAL IN233,037$3.5M0.7%
28KRYSKRYSTAL BIOTECH INC9,970$3.3M0.6%
29BNTXBIONTECH SE32,100$3.2M0.6%
30SRPTSAREPTA THERAPEUTICS INC166,605$3.0M0.6%
31ABEVAMBEV SA989,723$2.9M0.6%
32CRSPCRISPR THERAPEUTICS AG48,974$2.7M0.5%
33MGTXMEIRAGTX HLDGS PLC208,512$2.3M0.4%
34BEAMBEAM THERAPEUTICS INC91,282$2.2M0.4%
35ZTSZOETIS INC23,643$1.7M0.3%
36BTGB2GOLD CORP265,505$1.4M0.3%
37FDMT4D MOLECULAR THERAPEUTICS IN90,110$1.3M0.3%
38TSHATAYSHA GENE THERAPIES INC232,900$1.1M0.2%
39RNACCARTESIAN THERAPEUTICS INC155,000$1.1M0.2%
40FATEFATE THERAPEUTICS INC414,311$981,9170.2%
41AUTLAUTOLUS THERAPEUTICS LTD469,490$910,8110.2%
42RIGTRANSOCEAN LTD155,699$815,8630.2%
43MOHMOLINA HEALTHCARE INC4,064$768,5020.1%
44LULULULULEMON ATHLETICA INC7,023$675,5420.1%
45RCKTROCKET PHARMACEUTICALS INC244,146$642,1040.1%
46NOVNOV INC34,050$637,7570.1%
47LXEOLEXEO THERAPEUTICS INC155,000$523,9000.1%
48SDSANDRIDGE ENERGY INC38,792$523,3040.1%
49NUNU HLDGS LTD38,168$483,2070.1%
50SASEABRIDGE GOLD INC14,172$401,6340.1%
51URNMSPROTT FDS TR8,178$388,1280.1%
52ENGNENGENE THERAPEUTICS INC170,000$340,0000.1%
53VYGRVOYAGER THERAPEUTICS INC120,000$321,6000.1%
54RRCRANGE RES CORP7,147$264,7250.1%
55EXEEXPAND ENERGY CORPORATION3,046$256,1380%
56EQTEQT CORP5,266$255,7170%
57PFEPFIZER INC7,406$211,2190%
58COPYRBB FUND TRUST13,250$202,9900%

Source: SEC Form 13F-HR, reporting period 2026-09-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.